K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct

Cancer

Volumn 77, Issue 3, 1996, Pages 452-458

  Hanada, Keiji ^a   Itoh, Masaki ^a   Fujii, Kiyomu ^a   Tsuchida, Akira ^a   Ooishi, Hideo ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

anomalous junction of the pancreaticobiliary duct; carcinogenesis; gallbladder carcinoma; K ras; p53; risk factor

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BILE DUCT MALFORMATION; CANCER CELL CULTURE; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GALLBLADDER CARCINOMA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE K RAS; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; BASE SEQUENCE; COMMON BILE DUCT; FEMALE; GALLBLADDER NEOPLASMS; GENES, P53; GENES, RAS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; PANCREATIC DUCTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030028136     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M     Document Type: Article

References (27)

1. Komi N, Udaka H, Ikeda N, Kashiwagi Y. Congenital dilatation of the biliary tracts: new classification and study with particular reference to anomalous arrangement of the pancreaticobiliary ducts. Gastroenterol Jpn 1977;12:293-304.
2. Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, et al. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 1985;89:1258-65.
3. Kinoshita H, Nagata E, Hirohashi K, Sakai K, Kobayashi Y. Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct. Cancer 1984;54:762-9.
4. Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 1987;82:20-4.
5. Ohta T, Nagakawa T, Ueno K, Maeda K, Ueda N, Kayahara M, et al. Clinical experience of biliary tract carcinoma associated with anomalous union of the pancreaticobiliary ductal system. Jpn J Surg 1990;20:36-43.
6. Yamamoto M, Nakajo S, Tahara E, Ito M, Taniyama K, Shimamoto F, et al. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract 1991;187:241-6.
7. Ueda N, Nagakawa T, Ohta T, Kayahara M, Ueno K, Konishi I, et al. Synchronous cancer of the biliary tract and pancreas associated with anomalous arrangement of the pancreaticobiliary ductal system. J Clin Gastroenterol 1992;15:136-41.
8. Sameshima Y, Uchimura M, Muto Y, Maeda J, Tsuchiyama H. Coexistent carcinoma in congenital dilatation of the bile duct and anomalous arrangement of the pancreatico-bile duct. Cancer 1987;60:1883-90.
9. Ozmen V, Martin PC, Igci A, Cevikbas U, Webb WR. Adenocarcinoma of the gallbladder associated with congenital choledochal cyst and anomalous pancreaticobiliary ductal junction. Eur J Surg 1991;157:549-51.
10. Nagata E, Sakai K, Kinoshita H, Kobayashi Y. The relation between carcinoma of the gallbladder and an anomalous connection between the choledochus and the pancreatic duct. Ann Surg 1985;202:182-90.
11. Fenoglio-Preiser CM. Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer. Cancer 1992;69:1607-32.
12. Wee A, The M, Raju GC. Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J Clin Pathol 1994;47:453-6.
13. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-53.
14. Wistuba H, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995;55:2511-5.
15. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. Philadelphia: JB Lippincott Company, 1992.
16. Berrozpe G, Schaeffer J, Peinado MA, Real FX, Perucho M. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994;58:185-91.
17. Simon B, Weinel R, Hohne M, Watz J, Schmidt J, Kortner G, et al. Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology 1994;106:1645-51.
18. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
19. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S, Itakura M. Role of p53 mutations in endocrine tumorgenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res 1992;52:5061-4.
20. Babbit DP, Starshak RJ, Clemett AR. Choledochal cyst: a concept of etiology. Am J Roentgenol 1973;119:57-62.
21. Tada M, Yokosuka O, Omata M, Ohto M, Isono K. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990;66:930-5.
22. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
23. Kato T, Matsuda K, Kayaba H, Enomoto S, Tamura H, Hebiguchi T, et al. Pathological condition of anomalous choledoco-pancreatic ductal junction. Mutagenicity of biliary tract contents and fluorometric analysis of DNA content of biliary epithelia. [in Japanese with English abstract] J Jpn Biliary Assoc 1987;1:377-83.
24. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-54.
25. Smit VTHBM, Boot AMM, Fleuren GF, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988;16:7773-82.
26. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y. p53 and c-erb B-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993;170:67-72.
27. Takagi S, Naito E, Yamanouchi H, Ohtsuka H, Kominami R, Yamamoto M. Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med 1994;172:283-9.